Indications
Myrbetriq (active ingredient: mirabegron) is a prescription medication indicated for:
- Treatment of Overactive Bladder (OAB): Myrbetriq is used to treat the symptoms of overactive bladder, such as urgency, frequency, and urge urinary incontinence (the sudden need to urinate that can't be controlled, leading to involuntary leakage of urine).
Myrbetriq belongs to the drug class known as beta-3 adrenergic agonists.
Uses and Dosage
Patients should take Myrbetriq strictly according to the instructions of a physician or healthcare professional. It is important to swallow the tablets whole with a full glass of water; crushing or chewing the tablets may reduce the effectiveness of the medication.
The recommended starting dose of Myrbetriq (mirabegron) is 25 mg taken orally once daily, either with or without food. However, children must take Myrbetriq with food. Generally, efficacy can be expected within 8 weeks of treatment, and the dose may be increased to 50 mg once daily if necessary. It is important to take Myrbetriq exactly as prescribed and to swallow the tablets whole; do not crush, divide, or chew the tablets.
Side Effect
Common Side Effect of Mirabegron May Includes
- Bladder pain
- Bloody or cloudy urine
- Difficult, burning, or painful urination
- Dizziness
- Frequent urge to urinate
- Headache
- Lower back or side pain
- Nervousness
- Pounding in the ears
- Slow, fast, or irregular heartbeat
Serious Side Effects of Myrbetriq
- Blurred vision
- Fast or pounding heartbeats
- High blood pressure
- Pain or burning when you urinate
- Painful or difficult urination
- Pounding in your neck or ears
- Severe headache
- Trouble emptying your bladder
Form and Strength
Myrbetriq and its generic alternative Mirabegron available in the following forms and strength:
Myrbetriq: Extended-Release Tablet
- 25 mg
- 50 mg
Mirabegron: Extended-Release Tablet
- 25 mg
- 50 mg
Caution
Possible cautions of Myrbetriq include:
- It should not be used in patients with moderate or severe hepatic impairment.
- It should not be used in patients with severe renal impairment or end stage renal disease.
- It should not be used in patients with uncontrolled hypertension.
- It should not be used in patients with a history of urinary retention.
- It should not be used in patients with certain conditions such as narrow-angle glaucoma.
- It should not be used in patients with known hypersensitivity to Myrbetriq or any of its ingredients.
- It should not be used in patients taking a monoamine oxidase inhibitor (MAOI).
- It should not be used in pregnant women unless the potential benefit to the mother outweighs the potential risk to the fetus.
- It should not be used in nursing mothers unless the potential benefit to the mother outweighs the potential risk to the infant.
Frequently Asked Questions (FAQ)
Some Frequently Asked Questions (FAQs) about Myrbetriq (mirabegron) include:
What is Myrbetriq used for?
Myrbetriq is used to treat overactive bladder (OAB) with symptoms of frequent urination, urgency, and urgent incontinence.
What is the recommended starting dose of Myrbetriq?
The recommended starting dose of Myrbetriq is 25 mg taken orally once daily, either with or without food. However, children must take Myrbetriq with food.
Can Myrbetriq be split, crushed, or chewed?
No, Myrbetriq should be swallowed whole and should not be split, crushed, or chewed. Doing so may release the active ingredients all at once and increase the risk of adverse effects.
How long does it take for Myrbetriq to start working?
Myrbetriq usually starts to work within a few days of taking it. However, it can take up to 8 weeks for Myrbetriq to reach its full effect.
Is Myrbetriq safe to take?
Myrbetriq is generally safe to take, and it has been studied in clinical trials. However, like all medications, it can cause side effects in some people. Talk to your doctor if you are concerned about taking Myrbetriq.
Resources
- https://www.mayoclinic.org/drugs-supplements/mirabegron-oral-route/side-effects/drg-20075675
- https://www.rxlist.com/myrbetriq-side-effects-drug-center.htm
- https://www.webmd.com/drugs/2/drug-162243-1495/myrbetriq-oral/mirabegron-extended-release-oral/details
- https://www.healthline.com/health/drugs/myrbetriq#side-effects
REVIEWS